SAN–Cardiac Plexus Assembloids Model Maturation

Study Background and Research Question

The sinoatrial node (SAN) is the primary pacemaker of the human heart. It generates spontaneous electrical impulses that initiate each heartbeat and then pass into the atrial myocardium. SAN activity is not determined by pacemaker cells alone: intrinsic cardiac neural inputs, including those associated with the right atrial ganglionated plexus, modulate firing rate, pacemaker dominance, and impulse propagation. This neuro-cardiac relationship is therefore central to human rhythm physiology and to the study of conduction disorders.

Existing experimental models capture only part of this biology. Human pluripotent stem cell differentiation can produce SAN-like pacemaker cells, but many two-dimensional systems lack the three-dimensional organization, cellular diversity, atrial coupling, and neural inputs of the native tissue. Cardiac organoids provide a broader developmental context, yet conventional organoids are not necessarily specialized enough to reproduce the regional architecture of the SAN or its interaction with intrinsic cardiac neurons.

The reference study, Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems, addresses this gap. The central question is whether human pluripotent stem cell-derived tissues can be assembled into an experimentally tractable model in which neural inputs influence pacemaker maturation and SAN-to-atrial conduction. The study also asks whether functional analysis of the model can be integrated with spatial information from human SAN tissue to identify candidate neuron-to-pacemaker signaling mechanisms. The findings are reported in the reference study.

Key Innovation from the Reference Study

The principal innovation is the construction of SAN-plexus assembloids rather than a pacemaker model composed of a single differentiated cell population. The authors integrate human pluripotent stem cell-derived SAN organoids, or SANOs, with cardiac ganglionated plexus organoids, or CGPOs. They further introduce atrial-like cardiac organoids to create a tri-assembloid arrangement that enables analysis of pacemaker-to-atrial coupling.

This design is important because it treats pacemaker function as an interaction among specialized myocardial and neural compartments. A SAN-like cell population can display spontaneous activity in isolation, but the physiological meaning of that activity depends on whether impulses can exit the node, reach atrial tissue, and respond to neural modulation. The assembloid framework places these questions in one human, three-dimensional experimental system.

The study also combines model construction with human tissue analysis. Spatial transcriptomics of human SAN tissue was used alongside functional studies in the assembloids. This cross-validation strategy moves beyond a list of differentially expressed genes: it asks whether spatially localized human SAN expression patterns correspond to a signaling interaction that can be tested experimentally. The resulting candidate pathway involves CGPO-derived prosaposin engaging the SAN-enriched receptor GPR37, a signaling relationship associated with pacemaker maturation according to the published report.

Methods and Experimental Design Insights

The experimental logic proceeds through several linked layers. First, the researchers generate regionally specialized organoids from human pluripotent stem cells. SANOs provide the pacemaker compartment, whereas CGPOs provide intrinsic cardiac neural tissue. Atrial-like cardiac organoids serve as a receiving myocardial compartment, allowing the investigators to evaluate conduction beyond the SAN itself.

Second, the components are brought together as assembloids. This physical integration is more informative than simply mixing dissociated cells because it preserves local tissue organization and creates a platform in which neuronal projections, pacemaker cells, and atrial-like myocardium can interact. Structural characterization establishes whether the intended compartments are present and integrated. Molecular characterization examines the identity and maturation state of the assembled tissues, while electrophysiological analysis addresses spontaneous pacemaking, impulse propagation, and neural modulation.

The molecular framework is consistent with established SAN biology. Pacemaker identity is associated with regulators such as SHOX2, ISL1, and TBX3, together with ion-channel features including HCN4, whereas transitional regions may retain aspects of working myocardium that support conduction into the atria. These markers should be interpreted as part of a broader identity and maturation panel rather than as proof of fully adult SAN equivalence.

A major methodological strength is the connection between spatial transcriptomics and functional perturbation. Spatial data can identify receptor and ligand enrichment in anatomically relevant regions, but enrichment alone does not establish a working signaling pathway. Functional assembloid experiments provide a route to test whether a candidate neural signal changes pacemaker properties. In this study, that combined strategy supports investigation of the prosaposin–GPR37 axis as a neuron-to-pacemaker maturation program.

Protocol Parameters

• Organoid composition: Assemble SANOs with CGPOs and atrial-like cardiac organoids when the experimental objective includes both neural modulation and SAN-to-atrial conduction. The reference study establishes this integrated design; exact organoid ratios and assembly timing should be taken from the full protocol rather than inferred from the summary.
• Identity quality control: Verify pacemaker, neural, and atrial-like compartments with orthogonal molecular and structural assays before interpreting functional differences as maturation effects.
• Baseline electrophysiology: Record spontaneous activity and conduction in the assembled system before pharmacological or genetic perturbation. Baseline measurements are essential for separating developmental maturation from acute chronotropic responses.
• Neural-dependence controls: Where feasible, compare integrated assembloids with appropriate component or signaling controls. This is a workflow recommendation for testing whether an observed phenotype requires CGPO-derived input; it is not presented as an exact control scheme from the condensed report.
• Beta-adrenergic extension: A concentration-response design with vehicle controls, time-resolved recordings, and washout can be added to examine beta-adrenergic receptor signaling. This pharmacological extension was not identified as a reported intervention in the study summary and should therefore be treated as a proposed assay module.
• Downstream signaling: Pair functional recordings with measurements related to GPCR signaling and the cAMP/PKA pathway when testing acute adrenergic regulation. These readouts can distinguish changes in pacemaker rate from longer-term effects on maturation.

Core Findings and Why They Matter

The SAN-plexus assembloids reproduce molecular, structural, and electrophysiological features associated with human pacemaker activity. Their significance is not simply that the tissues beat spontaneously. Rather, the model creates a setting in which spontaneous SAN-like activity can be examined together with neural organization and atrial-like coupling. This makes it better suited to questions about pacemaker system maturation than an isolated SAN-like cardiomyocyte culture.

The tri-assembloid configuration also provides a practical framework for studying conduction dysfunction. Because the system includes a pacemaker source and a downstream atrial-like target, researchers can investigate whether abnormal neural input, incomplete maturation, or defective coupling changes the movement of electrical activity through the model. The platform therefore connects cell identity to tissue-level function, an important step for cardiovascular research focused on rhythm disorders.

Another important finding is the identification of a CGPO-derived prosaposin–GPR37 signaling program. The study links prosaposin from the cardiac plexus compartment with GPR37 enrichment in SAN-related tissue and reports that this interaction promotes pacemaker maturation. The result offers a mechanistic explanation for how intrinsic cardiac neurons may influence the development of pacemaker properties rather than merely changing the acute firing rate of already mature cells.

This distinction has broad experimental value. Acute neural or receptor stimulation may alter automaticity within minutes, whereas maturation programs can affect cellular identity, electrical phenotype, and network integration over longer periods. The reference study provides a platform in which these timescales can be separated: investigators can examine baseline development, acute neural modulation, and longer-term signaling-dependent maturation within related experimental preparations.

The work also demonstrates why human tissue context matters. Animal models have established many principles of SAN formation and autonomic regulation, but species differences in electrophysiology and neural control can limit translation. Human SAN spatial data, combined with a human cell-derived functional model, may help prioritize signaling mechanisms that are more relevant to human pacemaker biology.

Comparison with Existing Internal Articles

The internal article SAN–Cardiac Plexus Assembloids Model Pacemaker Maturation provides a concise overview of the same study’s central platform and prosaposin–GPR37 finding. Its emphasis is on the assembloid concept and the integration of spatial transcriptomics with functional analysis. The present article extends that framing by focusing more explicitly on experimental logic, control structure, and how the model can be used to distinguish maturation from acute receptor-mediated modulation.

A second related resource, Modeling Human SAN-Neural Maturation via PSC-Derived Assembloids, emphasizes the value of human pluripotent stem cell-derived tissues for studying neuro-cardiac crosstalk. It is useful as a complementary conceptual summary, whereas the reference study itself remains the basis for the specific claims about SANOs, CGPOs, atrial-like organoids, electrophysiology, spatial transcriptomics, and GPR37-associated maturation. Neither internal article should be treated as an independent validation of those findings.

Limitations and Transferability

The model is a substantial advance, but it should not be equated with an intact adult human SAN. Organoids and assembloids may not reproduce the full intramural anatomy, vascular supply, extracellular matrix, mechanical loading, endocrine environment, immune context, or chamber-scale conduction network of the heart. A positive result in the platform therefore identifies a mechanism suitable for human in vitro investigation, not definitive evidence of its magnitude in vivo.

PSC-derived tissues can also vary with cell line, differentiation efficiency, organoid batch, and maturation state. These sources of variation make rigorous identity control, biological replication, and predefined electrophysiological endpoints important. Neural integration may be heterogeneous across assembloids, so apparent differences in automaticity or conduction should be evaluated alongside structural evidence of compartmental integration.

The prosaposin–GPR37 result is mechanistically informative, but spatial colocalization and functional association do not resolve every step of the signaling cascade. Further work is needed to establish how receptor activation changes pacemaker transcriptional programs, ion-channel regulation, synaptic or paracrine communication, and long-term electrical maturation. Loss-of-function and rescue experiments would be especially valuable for testing pathway specificity.

Transferability to pharmacology also requires care. Adrenergic agonists can produce acute changes in rate and excitability that may obscure slower developmental effects. Experiments designed around beta-adrenergic receptor signaling should therefore include time-resolved measurements, matched vehicle controls, and a clear distinction between acute cAMP/PKA pathway responses and changes in tissue maturation. These considerations make the assembloid system a flexible research platform, but not a substitute for clinical electrophysiology or in vivo validation.

Research Support Resources

For pharmacological studies that extend this platform toward controlled beta-receptor stimulation, researchers can use Isoproterenol sulfate dihydrate (SKU C6402), the hemisulfate salt form also described as Isoproterenol hemisulfate. It can support experiments examining beta-adrenergic receptor signaling, GPCR signaling, and cAMP/PKA pathway responses in human pacemaker or cardiac assembloid workflows; preparation and storage should follow the product information.